Navigation Links
Inclinix, Inc. Announces Executive Management Team Changes
Date:2/22/2008

WILMINGTON, N.C., Feb. 22 /PRNewswire/ -- Inclinix, Inc., an enrollment contract research organization (CRO) and provider of clinical trial recruitment solutions, announced today the following changes to its executive management team:

-- Steven M. Agnoff, has joined the company in the position of Vice

President of Marketing and Product Management. In this role, Mr. Agnoff

provides strategic direction to the corporate marketing and product

marketing functions of the company and oversees product management

efforts. Prior to joining Inclinix, Mr. Agnoff held executive

leadership and business development roles with organizations including

PDI, Inc., PharmaKon, Fenner PLC, Efson, Inc. and Interroll

Corporation.

-- Daniel D. Marks, has joined the company as Vice President of Corporate

Development. In this role, Mr. Marks is responsible for the evaluation

and execution of Inclinix's strategic investments, joint ventures and

acquisitions. Before joining Inclinix, he held executive management

roles within the technology and medical services sectors.

-- Jeffrey L. Bagshaw, has been named Senior Vice President of Sales. In

this role, Mr. Bagshaw is responsible for leading sales operations of

Inclinix. Prior to this role, he served as vice president of medical

marketing and communications at Inclinix. Prior to joining Inclinix,

Mr. Bagshaw held sales and marketing leadership roles at organizations

including Hoffman La Roche, Bristol Myers Squibb and Exact Sciences.

Newly-reporting to Mr. Bagshaw is:

-- Susan A. Jalbert, who has joined the company as Director of North

American Sales. In this role, Ms. Jalbert has responsibility for

managing strategic client relationship development and tactical sales

efforts with Inclinix's expanded sales team. Prior to joining

Inclinix, Ms. Jalbert held sales and business development leadership

positions at Medidata Solutions, Relsys International, Inc., Domain

Pharma Corporation, Neuromedical Systems, Inc. and the Corning

Nichols Institute. Now reporting to Ms. Jalbert are:

- Ashley Amstutz, sales executive;

- Jeffrey Cazeault, sales executive;

- Svetlana Gorodetsky, sales executive;

- Matt Granger, sales executive;

- Askold Kozbur, sales executive;

- Tom McCollum, senior sales executive;

- Stephen Scaldaferri, sales executive; and

- Christine Ward, sales executive.

CEO and President J. Tobin Geatz said: "We are excited to have these accomplished industry professionals on board to strengthen our leadership team. Having previously helped other innovative companies accelerate their revenues and growth paths, these executives, without doubt, are equipped and ready to guide Inclinix during this time of tremendous growth."

About Inclinix

Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO. Inclinix's IQM(TM) Intelligent Enrollment process uses technology to amplify traditional services and is proven to accelerate trials for pharmaceutical, biotechnology and medical-device organizations. In addition to its clinical research-related offerings, Inclinix provides strategic medical marketing communications and adherence services to the healthcare industry. For more information on Inclinix, visit http://www.inclinix.com


'/>"/>
SOURCE Inclinix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HCA Announces Preliminary Results for Its Debt Tender Offer
2. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
3. Air Methods Announces New Chief Operating Officer
4. Pacific Fertility Center Announces Breakthrough in Egg Freezing Technology
5. Neurochem announces departure of two members of management team
6. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
7. LCA-Vision Announces Quarterly Dividend Payment
8. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
9. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
10. IDM Pharma Announces Compliance With NASDAQ Minimum Bid Price Requirements
11. Derma Sciences Announces Several Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming APWCA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... , ... Salveo for life, a company that distributes an effervescent lime-flavored drink ... as part of its presence to expand its market reach. , Using a formula ... of nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst ...
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... that Redwood Family Dermatology has recently joined their multi-specialty medical group. ... full range of cosmetic services. , “We’re excited to add this excellent dermatology ...
(Date:1/20/2017)... ... 2017 , ... A new partnership between Goodwill® and Roadie, Inc. aims to ... from clothes to couches to dressers and bicycles. Roadie — the national on-the-way delivery ... Goodwill donation center through February 28th. , “January is an exciting time when ...
(Date:1/20/2017)... ... ... Lice Troopers, the lice removal company based in South Florida, has seen ... season. , “It happens every year around this time,” says owner, Arie Harel. ... is the head-to-head gateway that lice need to spread.” , As children return to ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin ... alternative VW+ 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic ... during your workout. , After a successful launch in Sweden last year, the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017   Science Exchange , the ... announce that the first five replication studies from ... been published in eLife today. Despite intense scrutiny ... first practical evaluation of reproducibility rates that may ... Unlike other assessments of reproducibility, the results of ...
(Date:1/19/2017)... New Review of Safinamide ... Symptoms and Motor Complications in Mid- to Late-stage ... ... C Warren Olanow ... 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late Published ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD ... Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical ... addition, technological enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
Breaking Medicine Technology: